This invention is in the fields of cancer therapy. More particularly it concerns compounds which are useful agents for inhibiting cell proliferative disorders, especially those disorders characterized by over activity and/or inappropriate activity of a EGFR, including EGFR-related cancers, and methods for treating these disorders.
这项发明涉及癌症治疗领域。更具体地,它涉及一些化合物,这些化合物是用于抑制细胞增殖异常的有效药物,特别是那些由
EGFR过度活跃和/或不适当活跃引起的疾病,包括
EGFR相关的癌症,并提供了治疗这些疾病的方法。